As displayed in Figure 8(b), TP53, AKT1, SRC, STAT3, MAPK3, PIK3CA, MAPK1, PIK3R1, HRAS, JUN, VEGFA, HSP90AA1, EGFR, JAK2, MAPK8, and JUN could be the potential target genes for KCMMs in the treatment of HCC. Here, HRAS is linked to hepatocellular carcinoma.